4 completed, 3 terminated, 1 unknown, 1 withdrawn. 5 Phase 2, 2 Not applicable, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Terminated 1, Unknown 1, Withdrawn 1 |
| Not applicable | 2 | Completed 2 |
| Phase 3 | 2 | Terminated 2 |
Follow Adenoviral Conjunctivitis: new trials by email Literature Review of Adenoviral Conjunctivitis trials Research Report on Adenoviral Conjunctivitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis IVIEW-1201, Placebo - Adenoviral Conjunctivitis | Phase 2 | Completed | IVIEW Therapeutics Inc. | 135 | 2023-02-20 | 2025-10-15 |
| OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis OKG-0301 - Adenoviral Conjunctivitis | Phase 2 | Unknown | Okogen | 219 | 2019-02-11 | 2022-04-21 |
| Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo SHP640, Placebo - Adenoviral Conjunctivitis | Phase 3 | Terminated | Shire | 156 | 2017-03-28 | 2021-06-09 |
| Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo SHP640, PVP-I 0.6%, Placebo - Adenoviral Conjunctivitis | Phase 3 | Terminated | Shire | 219 | 2017-03-27 | 2021-06-14 |
| Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) Iota-Carrageenan, Carmellose - Adenoviral Conjunctivitis | Phase 2 | Withdrawn | NicOx | 2017-01-01 | 2017-05-10 | |
| Reducing Adenoviral Patient Infected Days Betadine 5%, Artificial Tears - Conjunctivitis, Adenoviral Conjunctivitis | Not applicable | Completed | Washington University School of Medicine | 28 | 2015-03-23 | 2021-01-06 |
| Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis NVC-422 Solution, 0.3%, NVC-422 Vehicle Solution - Adenoviral Conjunctivitis | Phase 2 | Completed | NovaBay Pharmaceuticals, Inc. | 500 | 2012-05-01 | 2015-05-28 |
| An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis AL-46383A Ophthalmic Solution, AL-46383A Ophthalmic Solution Vehicle - Adenoviral Conjunctivitis | Phase 2 | Terminated | Alcon Research | 452 | 2009-06-01 | 2014-05-22 |
| Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears RPS Adeno Detector - Acute Conjunctivitis, Adenoviral Conjunctivitis | Not applicable | Completed | Rapid Pathogen Screening | 186 | 2004-12-01 | 2010-02-11 |
Conjunctivitis (4) · Adenoviridae Infections (1) · Conjunctivitis, Viral (1) · Eye Infections (1)
Conjunctival Diseases (4) · Eye Diseases (4) · Infections (3) · Virus Diseases (2) · DNA Virus Infections (1) · Eye Infections (1) · Eye Infections, Viral (1)
Carboxymethylcellulose Sodium (1) · Carrageenan (1) · Lubricant Eye Drops (1) · Povidone-Iodine (1) · Saline Solution (1)
Shire (2) · Alcon Research (1) · IVIEW Therapeutics Inc. (1) · NicOx (1) · NovaBay Pharmaceuticals, Inc. (1) · Okogen (1) · Rapid Pathogen Screening (1) · Washington University School of Medicine (1)
United States (5) · India (3) · Australia (2) · Germany (2) · Spain (2) · Austria (1) · Brazil (1) · Canada (1) · Estonia (1) · France (1) · Hungary (1) · Israel (1) · Italy (1) · Peru (1) · Poland (1)
Brigitte Duquesroix (1) · David Stroman, Ph.D. (1) · Elisabeth J Cohen, MD (1) · Frank Schirra, MD (1) · Kristian Kozich, MD (1) · Mae O Gordon, PhD (1) · Richard Davidson, MD (1) · Sally Scheib (1) · Shachar Tauber, MD (1)
2016 (2)